Unrated Drug recall · FDA · Published February 4, 2022

Junp Hydration MegMan Booster Recall: Unapproved Tadalafil Risk

Junp Hydration recalls MegMan Performance Booster capsules due to undeclared tadalafil, an unapproved drug ingredient. This product was marketed without FDA approval and poses health risks.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0557-2022Drug Junp Hydration ›

Recall notice

Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Take action

Contact the company

Recalling firmJunp Hydration LLC1013 Mcdonald Ave · Brooklyn, NY 11230-1009

✎ GovInfoNow plain-language explainer

Junp Hydration is recalling MegMan Performance Booster capsules because they contain undeclared tadalafil, an ingredient approved for male sexual enhancement. This makes the product an unapproved drug that could pose health risks. Read more at govinfonow.com/recall/35238-junp-hydration-megman-booster-recall-unapproved-tadalafil-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35238-junp-hydration-megman-booster-recall-unapproved-tadalafil-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0557-2022

Cite this page

“Junp Hydration MegMan Booster Recall: Unapproved Tadalafil Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35238-junp-hydration-megman-booster-recall-unapproved-tadalafil-risk. Based on FDA recall #D-0557-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0557-2022%22&limit=1).

The FDA announced on Feb. 4, 2022, that Junp Hydration LLC voluntarily recalled MegMan Performance Booster capsules because they contained undeclared tadalafil, an unapproved drug ingredient. The agency classified the recall as Class I.

How to tell if you have it

Brand: Junp Hydration
Product: MegMan Performance Booster, 800 mg capsules
Packaging: 10-count blisters in a carton
UPC: 8 48998 00091 2
ASIN: B08Z74KS88
Lot #: 2010291
Expiration: 01/07/2024
Quantity: 750 cartons
Distribution: Nationwide in the USA via Amazon Marketplace

The hazard

The product was marketed without an approved New Drug Application or Abbreviated New Drug Application. It was found to contain undeclared tadalafil, an ingredient found in FDA-approved products for the treatment of male sexual enhancement, making it an unapproved drug.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15), Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21), and Agebox iKids-Growth Night Formula (2025-10-28).

How to tell if you have this one

Check for MegMan Performance Booster capsules in 10-count blister packs with UPC 8 48998 00091 2. The product was sold with lot number 2010291 and expires January 7, 2024.

Brand
Junp Hydration
Product
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for MegMan Performance Booster capsules in 10-count blister packs with UPC 8 48998 00091 2.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Product was distributed nationwide in the USA via Amazon Marketplace” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4 months after the firm started it.

Feb 4, 2022Firm started the recall
Feb 11, 2022FDA classified it Class I
Feb 16, 2022Published in FDA’s Enforcement Report
Jun 9, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35238-junp-hydration-megman-booster-recall-unapproved-tadalafil-risk">Junp Hydration MegMan Booster Recall: Unapproved Tadalafil Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0557-2022 (February 4, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0557-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.